AU2019381269B2 - Methods of using a phenoxypropylamine compound to treat pain - Google Patents

Methods of using a phenoxypropylamine compound to treat pain Download PDF

Info

Publication number
AU2019381269B2
AU2019381269B2 AU2019381269A AU2019381269A AU2019381269B2 AU 2019381269 B2 AU2019381269 B2 AU 2019381269B2 AU 2019381269 A AU2019381269 A AU 2019381269A AU 2019381269 A AU2019381269 A AU 2019381269A AU 2019381269 B2 AU2019381269 B2 AU 2019381269B2
Authority
AU
Australia
Prior art keywords
pain
compound
paclitaxel
subject
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019381269A
Other languages
English (en)
Other versions
AU2019381269A1 (en
Inventor
Remy LUTHRINGER
Nadine Noel
Jay SAOUD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minerva Neurosciences Inc
Original Assignee
Minerva Neurosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Neurosciences Inc filed Critical Minerva Neurosciences Inc
Publication of AU2019381269A1 publication Critical patent/AU2019381269A1/en
Application granted granted Critical
Publication of AU2019381269B2 publication Critical patent/AU2019381269B2/en
Priority to AU2025204043A priority Critical patent/AU2025204043A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2019381269A 2018-09-04 2019-09-04 Methods of using a phenoxypropylamine compound to treat pain Active AU2019381269B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025204043A AU2025204043A1 (en) 2018-09-04 2025-05-30 Methods of using a phenoxypropylamine compound to treat pain

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862726800P 2018-09-04 2018-09-04
US62/726,800 2018-09-04
PCT/US2019/049492 WO2020101790A2 (en) 2018-09-04 2019-09-04 Methods of using a phenoxypropylamine compound to treat pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025204043A Division AU2025204043A1 (en) 2018-09-04 2025-05-30 Methods of using a phenoxypropylamine compound to treat pain

Publications (2)

Publication Number Publication Date
AU2019381269A1 AU2019381269A1 (en) 2021-03-18
AU2019381269B2 true AU2019381269B2 (en) 2025-03-06

Family

ID=69641874

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019381269A Active AU2019381269B2 (en) 2018-09-04 2019-09-04 Methods of using a phenoxypropylamine compound to treat pain
AU2025204043A Pending AU2025204043A1 (en) 2018-09-04 2025-05-30 Methods of using a phenoxypropylamine compound to treat pain

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025204043A Pending AU2025204043A1 (en) 2018-09-04 2025-05-30 Methods of using a phenoxypropylamine compound to treat pain

Country Status (15)

Country Link
US (2) US11766430B2 (https=)
EP (1) EP3846812A2 (https=)
JP (2) JP7439096B2 (https=)
KR (1) KR102886521B1 (https=)
CN (1) CN112955145A (https=)
AU (2) AU2019381269B2 (https=)
BR (1) BR112021004030A2 (https=)
CA (1) CA3110652A1 (https=)
CL (1) CL2021000531A1 (https=)
GB (1) GB2591937B (https=)
IL (1) IL281166B2 (https=)
MA (1) MA53565A (https=)
MX (1) MX2021002590A (https=)
UA (1) UA129837C2 (https=)
WO (1) WO2020101790A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021026480A2 (pt) 2019-06-28 2022-02-08 Univ Texas Método para reconstituir anamicina, método para preparar uma dose eficaz de uma formulação lipossômica reconstituída de anamicina e método para tratar câncer
JP2024520463A (ja) 2021-05-24 2024-05-24 メディコン ファーマシューティカルズ，インコーポレイテッド 化学療法誘発性末梢神経障害に関連する疼痛の処置
EP4272826A3 (en) * 2021-05-24 2024-01-17 Medicon Pharmaceuticals, Inc. Treating pain associated with diabetic peripheral neuropathy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720320B2 (en) * 1999-05-24 2004-04-13 Mitsubishi Pharma Corporation Phenoxypropylamine compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207343A (en) 1978-06-22 1980-06-10 Eli Lilly And Company 1-Phenyl-3-(substituted phenoxy)propylamines
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
ES2220582T3 (es) 1999-12-20 2004-12-16 Eli Lilly And Company Derivados de piperidina y su uso como antagonistas de receptor de serotonina.
ATE409475T1 (de) * 2001-02-20 2008-10-15 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
DK1423168T3 (da) * 2001-09-03 2006-05-15 Newron Pharm Spa Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
US20040147581A1 (en) 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
SA08280759B1 (ar) 2007-01-10 2011-05-04 سولفاي فارماسوتيكالز بي . في مركبات من عوامل مضادة لشبيه القنب – cb1 ومكونات هيكلية من مثبطات إعادة إمتصاص السيروتونين بأندلابين أو فلوكسامين
TW201039815A (en) 2009-04-13 2010-11-16 Resolvyx Pharmaceuticals Inc Compositions and methods for the treatment of inflammation
RU2424799C1 (ru) 2010-03-29 2011-07-27 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" Способ коррекции депрессивных расстройств производными тиетан-1,1-диоксида в эксперименте
DK2948143T3 (da) 2013-01-24 2021-07-26 Minerva Neurosciences Inc Anvendelse af phenoxypropylaminforbindelser til behandling af depression
WO2017205399A1 (en) * 2016-05-25 2017-11-30 Minerva Neurosciences, Inc. (2s)-1-[4-(3,4-dichlorophenyl)piperidin-l-yl]-3-[2-(5-methyl-l,3,4-oxadiazol-2-yl)benzo[b]furan-4-yloxy]propan-2-ol or its metabolite for treating anxiety disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720320B2 (en) * 1999-05-24 2004-04-13 Mitsubishi Pharma Corporation Phenoxypropylamine compounds

Also Published As

Publication number Publication date
US11766430B2 (en) 2023-09-26
IL281166A (en) 2021-04-29
KR102886521B1 (ko) 2025-11-17
WO2020101790A3 (en) 2020-07-09
UA129837C2 (uk) 2025-08-20
US20200069672A1 (en) 2020-03-05
IL281166B1 (en) 2025-04-01
AU2025204043A1 (en) 2025-06-19
JP2024056875A (ja) 2024-04-23
WO2020101790A2 (en) 2020-05-22
GB2591937B (en) 2023-06-07
EP3846812A2 (en) 2021-07-14
US20240016790A1 (en) 2024-01-18
JP7439096B2 (ja) 2024-02-27
MX2021002590A (es) 2021-05-31
CA3110652A1 (en) 2020-05-22
GB202104738D0 (en) 2021-05-19
IL281166B2 (en) 2025-08-01
KR20210061357A (ko) 2021-05-27
BR112021004030A2 (pt) 2021-06-22
AU2019381269A1 (en) 2021-03-18
MA53565A (fr) 2021-07-14
CN112955145A (zh) 2021-06-11
GB2591937A (en) 2021-08-11
CL2021000531A1 (es) 2021-10-08
JP2021536506A (ja) 2021-12-27

Similar Documents

Publication Publication Date Title
US20240016790A1 (en) Methods of using a phenoxypropylamine compound to treat pain
EP4243797B1 (en) Rapidly infusing platform and compositions for therapeutic treatment in humans
KR20030040201A (ko) 급성 통증, 만성 통증 및/또는 신경병성 통증 및 편두통을치료하기 위한 약학 조성물
EP1063995B1 (en) Combination for the treatment of alcohol dependence containing an opioid antagonist and a nmda receptor complex modulator
JP2026047365A (ja) 新規方法
WO2009128058A1 (en) Psycho-pharmaceuticals
CN108463224A (zh) sGC刺激剂用于胃肠功能障碍治疗的应用
KR20250129690A (ko) 피페리딘일-메틸-푸린 아민을 함유하는 약학적 조성물과 질환 및 병태 치료에서 이의 용도
CN105209445B (zh) 治疗运动障碍和相关病症的方法
US20110244057A1 (en) Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
TWI874362B (zh) 使用苯氧丙胺化合物治療疼痛的方法
RU2797615C2 (ru) Способы применения феноксипропиламинового соединения для лечения боли
PL231163B1 (pl) Kombinacja i kompozycja farmaceutyczna do zastosowania w leczeniu i/lub zapobieganiu bólowi z powodu umiarkowanych do ciężkich neuralgii o różnorodnym umiejscowieniu
EP2498606A1 (en) Tivozanib and temsirolimus in combination
US12303503B1 (en) Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inhibitors for the treatment of pain
EP3463296A1 (en) Pharmaceutical formulations of nitrite uses thereof
JP2025087929A (ja) うつ病および／またはうつ状態の治療および／または予防用医薬

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)